ReviewDEN open2027
Therapeutic Balloon-Assisted Enteroscopy: Recent Advances in the Management of Small Bowel Diseases.
Review in DEN open, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Balloon-assisted enteroscopy (BAE) has substantially advanced small bowel disease management. This review summarizes recent therapeutic BAE advances, focusing on three major indications: small bowel vascular lesions, hereditary polyposis syndromes, and Crohn's disease (CD). For suspected small bowel bleeding from vascular lesions, morphological classification guides lesion-specific hemostasis-primarily using argon plasma coagulation and clipping-while gel immersion endoscopy helps secure the visual field. In hereditary polyposis syndromes (e.g., Peutz-Jeghers syndrome and familial adenomatous polyposis), endoscopic ischemic and cold snare polypectomy prevent intussusception and reduce cancer risk, decreasing surgical needs. Additionally, endoscopic balloon dilation is an established bowel-preserving treatment for fibrotic CD strictures, reducing surgical resection and short bowel syndrome risk. Driven by evolving imaging and devices, BAE remains central to small bowel management, improving patient outcomes and quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.